EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1

Anavex Life Sciences Corp.: Exhibit 99.1 - Filed by newsfilecorp.com

ANAVEX LIFE SCIENCES CORP.
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
July 15, 2015 and September 30, 2014
(Unaudited)

ASSETS
		July 15,			September 30,
		2015			2014
Current
Cash	$	8,025,039		$	7,262,138
Prepaid expenses		16,054			89,117
Total current assets		8,041,093			7,351,255
Equipment		1,749			2,247
Total assets	$	8,042,842		$	7,353,502
LIABILITIES
Current
Accounts payable and accrued liabilities	$	911,040		$	1,249,084
Promissory notes payable		90,412			192,065
Total current liabilities		1,001,452			1,441,149
Non-interest bearing liabilities		16,990			5,719,727
Total liabilities		1,018,442			7,160,876
STOCKHOLDERS' EQUITY
Capital stock
Authorized:         400,000,000 common shares, par value $0.001 per share    Issued and outstanding:         95,562,007 common shares (September 30, 2014 - 47,200,237)		95,563			47,201
Additional paid-in capital		66,807,196			52,078,750
Common stock to be issued		777,415			640,000
Accumulated deficit		(60,655,774	)		(52,573,325	)
Total stockholders' equity		7,024,400			192,626
Total liabilities and stockholders' equity	$	8,042,842		$	7,353,502